Abstract
Patients with cholinergic urticaria (CU) show a number of small, short-lasting hives when their body core temperature increases, usually during sweating following exercise or bathing. The precise mechanism(s) of hive formation in CU has been unclear except for the involvement of acetylcholine. We recently reported that most CU patients show immediate-type skin responses to their own sweat, whereas the rest of CU patients have positive autologous serum skin tests (ASSTs). The former group produced satellite wheals following acetylcholine injection, whereas the latter group produced hives in conjunction with hair follicles. We propose two subtypes of CU: 1) a sweat-hypersensitivity type with strong hypersensitivity to autologous sweat, nonfollicular hives, development of satellite wheals, and lack of positive ASST; and 2) a follicular type with follicular hives and positive ASST, but no hypersensitivity to autologous sweat or satellite wheals. We discuss the mechanisms of hive formation in these subtypes.
Similar content being viewed by others
References and Recommended Reading
Duke WW: Urticaria caused specifically by the action of physical agents. J Am Med Assoc 1924, 83:3–9.
Moore-Robinson M, Warin RP: Some clinical aspects of cholinergic urticaria. Br J Dermatol 1968, 80:794–799.
Hirschmann JV, Lawlor F, English JS, et al.: Cholinergic urticaria. A clinical and histologic study. Arch Dermatol 1987, 123:462–467.
Poon E, Seed PT, Greaves MW, Kobza-Black A: The extent and nature of disability in different urticarial conditions. Br J Dermatol 1999, 140:667–671.
Adachi J, Aoki T, Yamatodani A: Demonstration of sweat allergy in cholinergic urticaria. J Dermatol Sci 1994, 7:142–149.
Fukunaga A, Bito T, Tsuru K, et al.: Responsiveness to autologous sweat and serum in cholinergic urticaria classifies its clinical subtypes. J Allergy Clin Immunol 2005, 116:397–402.
Tupker RA, Doeglas HM: Water vapour loss threshold and induction of cholinergic urticaria. Dermatologica 1990, 181:23–25.
Zuberbier T, Althaus C, Chantraine-Hess S, Czarnetzki BM: Prevalence of cholinergic urticaria in young adults. J Am Acad Dermatol 1994, 31:978–981.
Shoenfeld Y, Harari Z, Sheonfeld Y, Keren G: Cholinergic urticaria. A seasonal disease. Arch Intern Med 1981, 141:1029–1030.
Takahagi S, Tanaka T, Ishii K, et al.: Sweat antigen induces histamine release from basophils of patients with cholinergic urticaria associated with atopic diathesis. Br J Dermatol 2008, 160:426–428.
Kaplan AP, Natbony SF, Tawil AP, et al.: Exercise-induced anaphylaxis as a manifestation of cholinergic urticaria. J Allergy Clin Immunol 1981, 68:319–324.
Lawrence CM, Jorizzo JL, Kobza-Black A, et al.: Cholinergic urticaria with associated angio-oedema. Br J Dermatol 1981, 105:543–550.
Soter NA, Wasserman SI: Physical urticaria/angioedema: an experimental model of mast cell activation in humans. J Allergy Clin Immunol 1980, 66:358–365.
Ormerod AD, Kobza-Black A, Milford-Ward A, Greaves MW: Combined cold urticaria and cholinergic urticaria: clinical characterization and laboratory findings. Br J Dermatol 1988, 118:621–627.
Kaplan AP, Garofalo J: Identification of a new physically induced urticaria: cold-induced cholinergic urticaria. J Allergy Clin Immunol 1981, 68:438–441.
Davis RS, Remigio LK, Schocket AL, Bock SA: Evaluation of a patient with both aquagenic and cholinergic urticaria. J Allergy Clin Immunol 1981, 68:479–483.
Mihara S, Hide M: Adrenergic urticaria in a patient with cholinergic urticaria. Br J Dermatol 2008, 158:629–631.
Onn A, Levo Y, Kivity S: Familial cholinergic urticaria. J Allergy Clin Immunol 1996, 98:847–849.
Kaplan AP, Gray L, Shaff RE, et al.: In vivo studies of mediator release in cold urticaria and cholinergic urticaria. J Allergy Clin Immunol 1975, 55:394–402.
Soter NA, Wasserman SI, Austen KF, McFadden ER Jr: Release of mast-cell mediators and alterations in lung function in patients with cholinergic urticaria. N Engl J Med 1980, 302:604–608.
Winkelmann RK: Cholinergic urticaria shows neutrophilic inflammation. Acta Derm Venereol 1985, 65:432–434.
Itakura E, Urabe K, Yasumoto S, et al.: Cholinergic urticaria associated with acquired generalized hypohidrosis: report of a case and review of the literature. Br J Dermatol 2000, 143:1064–1066.
Kobayashi H, Aiba S, Yamagishi T, et al.: Cholinergic urticaria, a new pathogenic concept: hypohidrosis due to interference with the delivery of sweat to the skin surface. Dermatology 2002, 204:173–178.
Hopkins JG, Kesten BM, Hazel OG: Urticaria provoked by heat or by psychic stimuli. Arch Dermatol Syph 1938, 38:679.
Grant RT, Pearson RSB, Comeau WJ: Observation on urticaria provoked by emotion, by exercise and by warming the body. Clin Sci 1936, 2:253–272.
Commens CA, Greaves MW: Tests to establish the diagnosis in cholinergic urticaria. Br J Dermatol 1978, 98:47–51.
Illig L, Heinicke A: On the pathogenesis of cholinergic urticaria. IV. On the problem of a true antigen-antibody reaction [in German]. Arch Klin Exp Dermatol 1967, 229:360–371.
Sigler RW, Levinson AI, Evans R, et al.: Evaluation of a patient with cold and cholinergic urticaria. J Allergy Clin Immunol 1979, 63:35–38.
Murphy GM, Greaves MW, Zollman PE, Winkelmann RK: Cholinergic urticaria, passive transfer experiments from human to monkey. Dermatologica 1988, 177:338–340.
Fantozzi R, Masini E, Blandina P, et al.: Release of histamine from rat mast cells by acetylcholine. Nature 1978, 273:473–474.
Nakazato Y, Tamura N, Ohkuma A, et al.: Idiopathic pure sudomotor failure: anhidrosis due to deficits in cholinergic transmission. Neurology 2004, 63:1476–1480.
Fukunaga A, Sato M, Horikawa T, Nishigori C: Acquired idiopathic generalized anhidrosis: a possible role of mast cell in the pathogenesis. Br J Dermatol 2009, 160:1337–1340.
Sulzburger MB, Herrmann FAB, Strauss MB: Studies of sweating. VI. On the urticariogenic properties of human sweat. J Invest Dermatol 1953, 21:293–303.
Adachi K, Aoki T: IgE antibody to sweat in atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1989, 144:83–87.
Hide M, Tanaka T, Yamamura Y, et al.: IgE-mediated hypersensitivity against human sweat antigen in patients with atopic dermatitis. Acta Derm Venereol 2002, 82:335–340.
Tanaka A, Tanaka T, Suzuki H, et al.: Semi-purification of the immunoglobulin E-sweat antigen acting on mast cells and basophils in atopic dermatitis. Exp Dermatol 2006, 15:283–290.
Valenta R, Seiberler S, Natter S, et al.: Autoallergy: a pathogenetic factor in atopic dermatitis? J Allergy Clin Immunol 2000, 105:432–437.
Hide M, Francis DM, Grattan CE, et al.: Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993, 328:1599–1604.
Sabroe RA, Grattan CE, Francis DM, et al.: The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999, 140:446–452.
Sabroe RA, Fiebiger E, Francis DM, et al.: Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 2002, 110:492–499.
Grattan CE, Francis DM, Hide M, Greaves MW: Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 1991, 21:695–704.
Asero R, Tedeschi A, Lorini M, et al.: Sera from patients with multiple drug allergy syndrome contain circulating histamine-releasing factors. Int Arch Allergy Immunol 2003, 131:195–200.
Tsunemi Y, Ihn H, Saeki H, Tamaki K: Cholinergic urticaria successfully treated with scopolamine butylbromide. Int J Dermatol 2003, 42:850.
Wong E, Eftekhari N, Greaves MW, Ward AM: Beneficial effects of danazol on symptoms and laboratory changes in cholinergic urticaria. Br J Dermatol 1987, 116:553–556.
La Shell MS, England RW: Severe refractory cholinergic urticaria treated with danazol. J Drugs Dermatol 2006, 5:664–667.
Kennes B, De Maubeuge J, Delespesse G: Treatment of chronic urticaria with a beta2-adrenergic stimulant. Clin Allergy 1977, 7:35–39.
Conway MJ: A beta-adrenergic blocker for cholinergic urticaria. Practitioner 1982, 226:940–941.
Feinberg JH, Toner CB: Successful treatment of disabling cholinergic urticaria. Mil Med 2008, 173:217–220.
Metz M, Bergmann P, Zuberbier T, Maurer M: Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy. Allergy 2008, 63:247–249.
Tanaka T, Ishii K, Suzuki H, et al.: Cholinergic urticaria successfully treated by immunotherapy with partially purified sweat antigen [in Japanese]. Arerugi 2007, 56:54–57.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Horikawa, T., Fukunaga, A. & Nishigori, C. New concepts of hive formation in cholinergic urticaria. Curr Allergy Asthma Rep 9, 273–279 (2009). https://doi.org/10.1007/s11882-009-0038-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11882-009-0038-x